Introduction: Addressing the Core Clinical Laboratory Pain Point – Safe, Reliable Blood Collection Without Cross-Contamination
For phlebotomists, laboratory technicians, and hospital procurement managers, the humble blood collection tube is far more than a simple container. It is the first link in the diagnostic chain, and any failure—breakage during handling, leakage during transport, contamination of the sample, or compromise of sterility—can render test results invalid, requiring a repeat draw that delays patient care and increases costs. The PET non-vacuum blood collection tube has become the standard for many clinical applications, particularly where vacuum-assisted collection is not required or when collecting small volumes from difficult venous access patients. Made primarily from polyethylene terephthalate (PET), these tubes offer several critical advantages: high transparency (allowing visual inspection of sample quality and clot formation), good mechanical strength (resisting breakage during centrifugation and transport), and strong rupture resistance (reducing biohazard exposure risk). Unlike glass tubes, PET tubes do not shatter when dropped, eliminating the risk of sharps injuries and sample loss. Used worldwide in hospitals, testing centers, and blood centers, these medical consumables are fundamental to modern clinical diagnostics. For CEOs of medical device companies, laboratory supply chain managers, and investors tracking the blood sample collection market, understanding the dynamics of this USD 2.31 billion and steadily growing market is essential.
Global Leading Market Research Publisher QYResearch announces the release of its latest report *”PET Non-vacuum Blood Collection Tube – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″*. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global PET Non-vacuum Blood Collection Tube market, including market size, share, demand, industry development status, and forecasts for the next few years.
Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/4946269/pet-non-vacuum-blood-collection-tube
Market Size & Growth Trajectory (2025-2031): A USD 2.31 Billion Market at 7.0% CAGR
According to QYResearch’s comprehensive analysis based on historical data from 2021 to 2025 and forecast calculations through 2032, the global market for PET Non-vacuum Blood Collection Tubes was valued at USD 1,441 million in 2024 and is projected to reach a readjusted size of USD 2,310 million by 2031, representing a compound annual growth rate (CAGR) of 7.0% during the forecast period from 2025 to 2031.
[Executive Insight for CEOs and Investors: The 7.0% CAGR reflects strong, sustainable growth driven by multiple factors: the expansion of healthcare access in emerging economies (increasing the number of blood draws performed annually), the outsourcing of laboratory testing to centralized commercial laboratories (requiring robust collection tubes for sample transport), and the ongoing replacement of glass collection tubes with PET equivalents in developed markets (driven by safety and cost considerations). The market also benefits from the steady increase in clinical laboratory testing volumes, as more diagnostic decisions are based on laboratory results.]
Based on QYResearch verified industry data, global sales of PET non-vacuum blood collection tubes reached 12 billion units in 2024, with an average selling price of approximately USD 0.12 per unit (calculated from market value and unit volume). This high-volume, low-unit-price product is manufactured at massive scale, with production lines optimized for efficiency.
Product Definition: Understanding PET Non-vacuum Blood Collection Tubes
PET non-vacuum blood collection tubes are a type of consumable widely used in clinical practice for collecting and preserving blood samples. They are made primarily from polyethylene terephthalate (PET), a thermoplastic polymer resin.
Unlike vacuum blood collection tubes, which contain a pre-measured vacuum to automatically draw a fixed volume of blood, non-vacuum tubes are used with a separate syringe or are filled by gravity or capillary action. They are preferred for:
- Collecting small volumes (e.g., pediatric patients, where vacuum tubes may draw too much)
- Collecting blood from patients with poor venous access (elderly, chemotherapy patients, critically ill)
- Collection methods not compatible with vacuum systems (e.g., from arterial lines or central venous catheters)
- Certain coagulation studies where the draw speed must be controlled
Key advantages of PET over glass include:
- Shatter resistance: PET tubes flex rather than shatter, reducing injury and biohazard exposure
- Light weight: PET tubes weigh approximately one-third of equivalent glass tubes, reducing shipping costs
- Clarity: PET offers optical clarity comparable to glass for sample visualization
- Disposal safety: Crushed or incinerated PET tubes do not produce sharp fragments
Product Segmentation: Capacity Ranges for Different Applications
The PET non-vacuum blood collection tube market is segmented by tube capacity (volume) into several categories serving different clinical needs.
Capacity 2-4 mL tubes are used for pediatric collections (minimizing blood draw volume from small patients), for specialized testing requiring small sample volumes, and for capillary blood collection from finger or heel sticks.
Capacity 10-15 mL tubes are the most commonly used range, suitable for routine chemistry, hematology, and serology testing in adults. This segment accounts for the largest share of unit volume.
Capacity 30-50 mL tubes are used for specialized applications requiring larger sample volumes: research studies, therapeutic drug monitoring, specialized coagulation testing, and blood bank compatibility testing.
Others includes tubes below 2 mL (micro-collection) and above 50 mL (large-volume research or veterinary applications).
Application Segmentation: Hospitals, Testing Agencies, and Others
By application, the PET non-vacuum blood collection tube market serves several end-user categories.
Hospital is the largest application segment. Hospital blood draws are performed on inpatients (during hospital stays), outpatients (visiting clinics or emergency departments), and pre-operative patients (for pre-surgical testing). Hospitals require reliable supply chains and compliance with regulatory standards (FDA, CE marking, ISO 13485 for medical devices).
Testing Agency (third-party medical testing organizations) is the fastest-growing segment. Commercial laboratories—including Dian Diagnostics (China), LabCorp (US), Quest Diagnostics (US), and others worldwide—perform outsourced testing for hospitals, clinics, and health systems. These organizations require high-volume, cost-effective collection tubes for sample transport from collection sites to central laboratories. The growth of centralized laboratory testing has been a significant driver for the PET non-vacuum tube market.
Others includes blood centers (collecting donor blood, though vacuum tubes or blood bags are more common), research laboratories, veterinary clinics, and public health testing sites.
Industry Value Chain: Upstream Raw Materials to Downstream Customers
The upstream raw materials for PET non-vacuum blood collection tubes include PET resin, additives (for clarity, strength, or surface properties), and rubber stoppers (for sealing tubes after filling). Major raw material suppliers include SABIC (Saudi Arabia, a global petrochemical leader), Mitsubishi Chemical (Japan), DuPont (US, specialty polymers), and Lanxess (Germany, specialty chemicals). The manufacturing process involves injection molding or injection stretch blow molding to form tube bodies, followed by cleaning, sterilization (typically ethylene oxide or gamma irradiation), and final packaging.
Downstream customers include hospitals (examples: Mayo Clinic in the US, Union Hospital in China), third-party medical testing organizations (Dian Diagnostics, LabCorp, Quest Diagnostics), and public health blood collection centers. Distribution channels include medical device distributors, direct sales to hospital systems, and group purchasing organizations (GPOs).
Competitive Landscape: Key Players (Partial List, Based on QYResearch Data)
The PET non-vacuum blood collection tube market features numerous regional and global manufacturers, with concentration varying by geography. Major players include KS Medical (Germany), BOENMED (China), Siny Medical (China), Chongqing New World Trading Company (China), Chengdu PUTH Medical Plastics Packaging Co., Ltd. (China), Krupa Labequi (India), Rollmed (China), Henso Medical (China), Nasmed Diagnostics Pvt. Ltd. (India), FUKANG (China), and Berpu Medical (China).
Based on corporate annual report disclosures and industry trade publications from 2024, the market is highly fragmented with no single dominant player. Chinese manufacturers collectively account for a significant share of global production, benefiting from lower manufacturing costs and scale. Quality differentiation is significant: premium manufacturers (typically European, US, Japanese) command higher pricing based on superior sterility assurance, lot-to-lot consistency, and regulatory certifications (CE, FDA 510(k) for certain applications).
*[Exclusive Industry Observation – Q1 2025 Update: The PET non-vacuum blood collection tube market is experiencing increased consolidation through manufacturer-distributor relationships. Major distributors (Medline, McKesson, Owens & Minor, Cardinal Health) prefer to work with a limited number of qualified suppliers who can demonstrate consistent quality and production capacity. This dynamic favors larger manufacturers with automated production lines and documented quality systems. Smaller manufacturers increasingly compete on regional presence, serving local hospital networks where direct relationships and shorter supply chains are valued.]*
Market Drivers: Healthcare Expansion, Lab Outsourcing, and Safety Concerns
Several drivers are accelerating the PET non-vacuum blood collection tube market.
Driver One: Global Healthcare Access Expansion. The expansion of healthcare access in emerging economies (including India, Indonesia, Nigeria, Brazil, and Southeast Asian nations) increases the number of blood draws performed annually. As these countries invest in healthcare infrastructure (hospitals, clinics, testing centers), demand for medical consumables including collection tubes grows in parallel.
Driver Two: Centralization of Laboratory Testing. The trend toward centralized commercial laboratories (outsourcing testing from individual hospitals to high-volume testing centers) increases demand for robust collection tubes that can withstand transport. Tubes must maintain sample integrity through potentially rough handling during courier transport, centrifugation upon arrival, and storage prior to testing.
Driver Three: Glass-to-PET Conversion in Developed Markets. In mature healthcare systems (North America, Western Europe, Japan), conversion from glass to PET tubes for non-vacuum applications continues. Regulatory guidance, safety committee recommendations, and purchasing policies increasingly specify shatter-resistant tubes (PET rather than glass) where performance is equivalent.
Driver Four: Increased Testing Volumes. Clinical laboratory testing volumes increase with population aging (elderly patients require more testing), chronic disease prevalence (diabetes, cardiovascular disease, cancer require monitoring), and the development of new diagnostic tests (including companion diagnostics for targeted cancer therapies).
Future Outlook (2025-2031): Strategic Implications for Decision-Makers
Over the forecast period, three transformative trends will shape the PET non-vacuum blood collection tube market. First, automated production will reduce manufacturing costs and improve consistency. High-speed injection molding lines (output exceeding 10,000 tubes per hour) and automated packaging systems (robotic sorting, bagging, boxing) are becoming standard. Second, upgraded sterility assurance technologies—including electron beam sterilization (faster, no chemical residues, allowing immediate release) compared to ethylene oxide (requires aeration)—will improve safety and reduce cycle times. Third, biodegradable alternative materials (including bio-based PET, polylactic acid or PLA, and other biodegradable polymers) will gain attention as healthcare systems pursue sustainability goals. While bio-based and biodegradable tubes currently command higher prices, volume scale may reduce the cost differential over the forecast period.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666 (US)
JP: https://www.qyresearch.co.jp
